nivolumab,bempegaldesleukin
bms,nektar
['nivo', 'bempeg', 'rcc,(-irccs),(-srcc),(-urcc)']
are cytokines still worth exploring in mrcc? hard to know given disappointing bempeg results reported at #esmo22. some anti-tumor activity of combo with nivo but not enough. pfs not reported (?). podcast with nizar coming soon.. 